Equities

Ami Organics Ltd

AMIORG:NSI

Ami Organics Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,631.30
  • Today's Change91.30 / 5.93%
  • Shares traded663.09k
  • 1 Year change+27.05%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 11:27 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments533587996
Total Receivables, Net2,7922,6751,693
Total Inventory1,6091,3941,335
Prepaid expenses24466.40
Other current assets, total--0.00261
Total current assets4,9584,7014,291
Property, plant & equipment, net4,8552,4731,808
Goodwill, net568203186
Intangibles, net10321181
Long term investments1.951717
Note receivable - long term5.517.45--
Other long term assets46140155
Total assets10,9597,6696,589
LIABILITIES
Accounts payable1,3461,4201,184
Accrued expenses------
Notes payable/short-term debt72600
Current portion long-term debt/capital leases304302.56
Other current liabilities, total476178106
Total current liabilities2,8521,6281,293
Total long term debt1,1366.265.88
Total debt2,166368.44
Deferred income tax1308863
Minority interest88----
Other liabilities, total136.814.36
Total liabilities4,2191,7301,366
SHAREHOLDERS EQUITY
Common stock369364364
Additional paid-in capital3,2572,7282,766
Retained earnings (accumulated deficit)3,1142,7762,050
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total--7143
Total equity6,7405,9405,223
Total liabilities & shareholders' equity10,9597,6696,589
Total common shares outstanding373636
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.